| Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD) P Golabi, M Otgonsuren, L de Avila, M Sayiner, N Rafiq, ZM Younossi Medicine 97 (13), 2018 | 196 | 2018 |
| Direct and indirect economic burden of chronic liver disease in the United States M Stepanova, L De Avila, M Afendy, I Younossi, H Pham, R Cable, ... Clinical Gastroenterology and Hepatology 15 (5), 759-766. e5, 2017 | 171 | 2017 |
| Cognitive Performance in Individuals with Non-alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus AA Weinstein, L de Avila, J Paik, P Golabi, C Escheik, L Gerber, ... Psychosomatics, 2018 | 42 | 2018 |
| Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor M Stepanova, M Sayiner, L de Avila, Z Younoszai, A Racila, ZM Younossi BMC gastroenterology 16 (1), 137, 2016 | 33 | 2016 |
| Hepatitis C Virus–Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens M Stepanova, A Thompson, J Doyle, I Younossi, L de Avila, ZM Younossi The Journal of Infectious Diseases 217 (7), 1033-1043, 2017 | 28 | 2017 |
| Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality N Fukui, P Golabi, M Otgonsuren, L de Avila, H Bush, ZM Younossi Alimentary pharmacology & therapeutics 47 (5), 680-688, 2018 | 21 | 2018 |
| The global epidemiology of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis P Golabi, N Fukui, L de Avila, J Paik, M Srishord, ZM Younossi Hepatology 66, 1177A-1178A, 2017 | 7 | 2017 |
| in Female Patients with Non-alcoholic Fatty Liver Disease (nafld), Presence of Type 2 Diabetes (dm) and Chronic Kidney Disease (ckd) are Independently Associated with the Risk … M Stepanova, L de Avila, A Birerdinc, B Noor, N Badoe, ZM Younossi Hepatology 62, 1282A-1283A, 2015 | 3 | 2015 |
| Changes in serum neurotransmitters (NTs) and patient-reported outcomes (PROs) and neurocognitive performance (NCP) after viral eradication of hepatitis C virus (HCV)-genotype 1 … L de Avila, AA Weinstein, P Golabi, JM Estep, C Escheik, A Birerdinc, ... Hepatology 66, 600A-600A, 2017 | 2 | 2017 |
| Can atherosclerotic cardiovascular risk score (ASCVD) predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)? P Golabi, N Fukui, M Otgonsuren, L de Avila, M Sayiner, ZM Younossi Journal of Hepatology 66 (1), S598, 2017 | 2 | 2017 |
| Non-alcoholic steatofibrosis is independently associated with both overall mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD) ZM Younossi, M Stepanova, N Rafiq, P Golabi, L de Avila, F Monge, ... Journal of Hepatology 66 (1), S598, 2017 | 2 | 2017 |
| 881-Insurance Coverage and Mortality in Patients with Hepatitis C Virus (HCV) Infection in the United States (US) H Bush, J Paik, P Golabi, L de Avila, C Escheik, ZM Younossi Gastroenterology 154 (6), S-1360, 2018 | 1 | 2018 |
| Psoriasis is Independently Associated with Non-Alcoholic Fatty Liver Disease CT Locklear, P Golabi, N Fukui, L de Avila, M Otgonsuren, M Afendy, ... Gastroenterology 152 (5), S1205, 2017 | 1 | 2017 |
| Long-Term Outcomes in Liver Transplant Recipients Transplanted from HCV-Positive Donors M Stepanova, M Sayiner, L De Avila, Z Younoszai, A Racila, ZM Younossi Journal of Hepatology 64 (2), S155, 2016 | 1 | 2016 |
| The Increase in the Circulating Chemokine Ligand 2 (CCL2) Levels in Patients with Chronic Hepatitis C Post Sustained Virologic Response (SVR) Is Not Associated with Detrimental … JM Estep, L de Avila, AA Weinstein, C Escheik, P Golabi, JK Price, ... HEPATOLOGY 68, 905A-906A, 2018 | | 2018 |
| Improvements in Patient Reported Outcomes after Sustained Virologic Response in Patients with Hepatitis C Virus Infection Correlates with Increases in Serotonin and Catechol-O … L de Avila, JM Estep, AA Weinstein, C Escheik, P Golabi, A Birerdinc, ... HEPATOLOGY 68, 916A-917A, 2018 | | 2018 |
| Su1525-Cognitive Function and Depression in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) and type 2 Diabetes Mellitus (T2DM): Analysis of the 2011–2014 National … L de Avila, AA Weinstein, J Paik, C Escheik, L Gerber, ZM Younossi Gastroenterology 154 (6), S-1167, 2018 | | 2018 |
| Hepatitis C Virus (HCV)-Infected Patients Receiving Opioid Substitution Therapy (OST) Experience Significant Increases in Patient-Reported Outcomes (PROs) Following Treatment … M Stepanova, AJ Thompson, JS Doyle, L de Avila, I Younossi, L Henry, ... HEPATOLOGY 66, 330A-330A, 2017 | | 2017 |
| Liver Transplant (LT) Candidates with Primary Biliary Cholangitis (PBC) Experience Higher Wait List Mortality: Data from the Scientific Registry of Transplant Recipients (SRTR) ZM Younossi, M Stepanova, L de Avila, A Ahmed, RJ Wong, S Saab, ... HEPATOLOGY 66, 176A-177A, 2017 | | 2017 |
| Relationship between Neurocognitive Performance (NCP) and Patient-Reported Outcomes (PROs) in Patients with Genotype 1 (GT1) Hepatitis C Virus (HCV) With or Without Viremia L de Avila, AA Weinstein, P Golabi, C Escheik, M Stepanova, MP Curry, ... HEPATOLOGY 66, 387A-388A, 2017 | | 2017 |
